COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 08:00, il y a 2 années 7 mois Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Publié le 15/09/2026 à 18:00, il y a 3 heures 54 minutes Compte-rendu d’Assemblée Générale Mixte du 10 septembre 2026
Publié le 15/09/2026 à 18:00, il y a 3 heures 54 minutes Report on the Combined General Meeting of the 10th of September 2026
Publié le 15/09/2026 à 17:45, il y a 4 heures 9 minutes EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Publié le 15/09/2026 à 17:45, il y a 4 heures 9 minutes FINALISATION DE L’ACQUISITION DU GROUPE NETCO
Publié le 15/09/2026 à 17:00, il y a 4 heures 54 minutes PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, Including 20.04 g/t Au over 0.85 m and 2251 g/t Ag With 3.0% Cu over 0.90 m
Publié le 15/09/2026 à 16:35, il y a 5 heures 19 minutes Innodata Appoints Admiral Michael S. Rogers, Former NSA Director and Commander of U.S. Cyber Command, to Its Board of Directors
Publié le 15/09/2026 à 15:45, il y a 6 heures 9 minutes Galaxy Ventures Inc. Announces Major Milestones for Qualifying Transaction: TruSilver Completes $2.5 Million Financing and Appoints Former IAMGOLD Chief Geologist Matt Rees as Director and Vice-President of Exploration
Publié le 15/09/2026 à 15:35, il y a 6 heures 19 minutes Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
Publié le 15/09/2026 à 15:25, il y a 6 heures 29 minutes Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
Publié le 15/09/2026 à 21:30, il y a 24 minutes ROSEWOOD HONG KONG NAMED NO.1 IN THE 50 BEST HOTELS 2026 FOR THE SECOND CONSECUTIVE YEAR
Publié le 15/09/2026 à 21:00, il y a 54 minutes HSA Group Launches AI Lab to Drive Its Next Era of Transformation
Publié le 15/09/2026 à 20:15, il y a 1 heure 39 minutes OCI publishes Position Statement in connection with the offer of NNS for all issued and outstanding OCI shares and convenes Extraordinary General Meeting of shareholders
Publié le 15/09/2026 à 19:50, il y a 2 heures 4 minutes SANY Heavy Truck Debuts Production-Ready Electric Truck Portfolio at IAA Transportation 2026